Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · IEX Real-Time Price · USD
4.400
-0.010 (-0.23%)
Apr 24, 2024, 3:49 PM EDT - Market closed
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $39.17 million as of April 24, 2024. Its market cap has increased by 295.68% in one year.
Market Cap
39.17M
Enterprise Value
24.06M
1-Year Change
295.68%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $39.17M, a decrease of -14.47%. That is a compound annual growth rate of -2.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 39.40M | 5.63% |
Apr 22, 2024 | 37.30M | 1.08% |
Apr 19, 2024 | 36.90M | 1.10% |
Apr 18, 2024 | 36.50M | -4.95% |
Apr 17, 2024 | 38.40M | -2.04% |
Apr 16, 2024 | 39.20M | -0.76% |
Apr 15, 2024 | 39.50M | 2.86% |
Apr 12, 2024 | 38.40M | -6.34% |
Apr 11, 2024 | 41.00M | -5.09% |
Apr 10, 2024 | 43.20M | 3.35% |
Apr 9, 2024 | 41.80M | -0.24% |
Apr 8, 2024 | 41.90M | 0.72% |
Apr 5, 2024 | 41.60M | -4.15% |
Apr 4, 2024 | 43.40M | 7.16% |
Apr 3, 2024 | 40.50M | 4.38% |
Apr 2, 2024 | 38.80M | -5.37% |
Apr 1, 2024 | 41.00M | 7.05% |
Mar 28, 2024 | 38.30M | -0.78% |
Mar 27, 2024 | 38.60M | 0.26% |
Mar 26, 2024 | 38.50M | -10.47% |
Mar 25, 2024 | 43.00M | -1.38% |
Mar 22, 2024 | 43.60M | 5.83% |
Mar 21, 2024 | 41.20M | 3.00% |
Mar 20, 2024 | 40.00M | 2.30% |
Mar 19, 2024 | 39.10M | 1.82% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Estrella Immunopharma | 41.00M |
NextCure | 40.98M |
Apollomics | 40.65M |
SAB Biotherapeutics | 40.59M |
Renalytix | 40.17M |
ProMIS Neurosciences | 39.85M |
Rapid Micro Biosystems | 39.80M |
Xilio Therapeutics | 39.68M |